Tag: NewLink Genetics
November 12, 2019
NewLink Genetics Receives European Commission Grant of Conditional Marketing Approval for V920
The European Commission has granted a conditional marketing authorization to ERVEBO, an investigational V920 Ebola Zaire vaccine.
October 6, 2019
5 Top NASDAQ Biotech and Pharma Stocks: Constellation Leads
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
September 30, 2019
NewLink Genetics and Lumos Pharma to Form Biopharma Company
The agreement is expected to close in Q1 2020. NewLink Genetics will change its name to Lumos Pharma and its... September 18, 2019
NewLink Genetics Receives FDA Acceptance for Partnered Biologics License Application
NewLink Genetics (NASDAQ:NLNK) has announced that the US Food and Drug Administration has accepted Merck’s (NYSE:MRK)’s Biologics License Application and...
May 26, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: Sesen Bio Up 40 Percent
Which NASDAQ biotech and pharma stocks were up last week? We examine the top five gainers and what may have... April 2, 2019
NewLink Genetics Presents Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019
NewLink Genetics (NASDAQ:NLNK) has announced results from its Phase 2 study of NLG207, a nanoparticle of the topoisomerase 1 inhibitor... November 15, 2018